Nantahala Capital Management, LLC Ikena Oncology, Inc. Transaction History

Nantahala Capital Management, LLC

  • $1.99 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$9.82 - $15.23 $3.43 Million - $5.33 Million
-349,660 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$13.27 - $26.0 $327,238 - $641,160
24,660 Added 7.59%
349,660 $4.91 Million
Q1 2021

May 14, 2021
BUY
$25.6 - $32.0 $8.32 Million - $10.4 Million
325,000 New
325,000 $9.18 Million

Others Institutions Holding IKNA

# of Institutions
56
Shares Held
32.9M
Call Options Held
0
Put Options Held
0
View Full List

About Ikena Oncology, Inc.

IKNA Quotes by TradingView
  • Ticker IKNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,257,500
  • Market Cap $54M
  • Description
  • Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...
More about IKNA
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email